These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16161725)

  • 1. A comparison of voucher exchanges between criminal justice involved and noninvolved participants enrolled in voucher-based contingency management drug abuse treatment programs.
    Roll JM; Prendergast ML; Sorensen K; Prakash S; Chudzynski JE
    Am J Drug Alcohol Abuse; 2005; 31(3):393-401. PubMed ID: 16161725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy.
    Silverman K; Higgins ST; Brooner RK; Montoya ID; Cone EJ; Schuster CR; Preston KL
    Arch Gen Psychiatry; 1996 May; 53(5):409-15. PubMed ID: 8624184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impulsivity and voucher versus money preference in polydrug-dependent participants enrolled in a contingency-management-based substance abuse treatment program.
    Reilly MP; Roll JM; Downey KK
    J Subst Abuse Treat; 2000 Oct; 19(3):253-7. PubMed ID: 11027895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contingency management for treatment of substance abuse.
    Stitzer M; Petry N
    Annu Rev Clin Psychol; 2006; 2():411-34. PubMed ID: 17716077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment at the front end of the criminal justice continuum: the association between arrest and admission into specialty substance abuse treatment.
    Kubiak SP; Arfken CL; Swartz JA; Koch AL
    Subst Abuse Treat Prev Policy; 2006 Jul; 1():20. PubMed ID: 16879743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contingency management voucher redemption as an indicator of delayed gratification.
    Fletcher JB; Dierst-Davies R; Reback CJ
    J Subst Abuse Treat; 2014 Jul; 47(1):73-7. PubMed ID: 24674235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of drug abuse treatment-linkage strategies.
    Sorensen JL; Masson CL; Delucchi K; Sporer K; Barnett PG; Mitsuishi F; Lin C; Song Y; Chen T; Hall SM
    J Consult Clin Psychol; 2005 Dec; 73(6):1026-35. PubMed ID: 16392976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vouchers versus prizes: contingency management treatment of substance abusers in community settings.
    Petry NM; Alessi SM; Marx J; Austin M; Tardif M
    J Consult Clin Psychol; 2005 Dec; 73(6):1005-14. PubMed ID: 16392974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contingency management interventions: from research to practice.
    Petry NM; Petrakis I; Trevisan L; Wiredu G; Boutros NN; Martin B; Kosten TR
    Am J Psychiatry; 2001 May; 158(5):694-702. PubMed ID: 11329388
    [No Abstract]   [Full Text] [Related]  

  • 11. Still HOPEful: Reconsidering a "failed" replication of a swift, certain, and fair approach to reducing substance use among individuals under criminal justice supervision.
    Humphreys K; Kilmer B
    Addiction; 2020 Oct; 115(10):1973-1977. PubMed ID: 32281705
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug Treatment Accessed through the Criminal Justice System: Participants' Perspectives and Uses.
    Rosenberg A; Heimer R; Keene DE; Groves AK; Blankenship KM
    J Urban Health; 2019 Jun; 96(3):390-399. PubMed ID: 30191511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring collaboration and integration activities in criminal justice and substance abuse treatment agencies.
    Fletcher B; Lehman W; Wexler H; Melnick G; Taxman F; Young D
    Drug Alcohol Depend; 2009 Aug; 103 Suppl 1():S54-S64. PubMed ID: 20088023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in naltrexone treatment compliance with contingency management.
    Preston KL; Silverman K; Umbricht A; DeJesus A; Montoya ID; Schuster CR
    Drug Alcohol Depend; 1999 Apr; 54(2):127-35. PubMed ID: 10217552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contingency management for cocaine treatment: cash vs. vouchers.
    Festinger DS; Dugosh KL; Kirby KC; Seymour BL
    J Subst Abuse Treat; 2014 Aug; 47(2):168-74. PubMed ID: 24746956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voucher-based contingent reinforcement of marijuana abstinence among individuals with serious mental illness.
    Sigmon SC; Higgins ST
    J Subst Abuse Treat; 2006 Jun; 30(4):291-5. PubMed ID: 16716843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs of criminal justice involvement among persons with serious mental illness in connecticut.
    Swanson JW; Frisman LK; Robertson AG; Lin HJ; Trestman RL; Shelton DA; Parr K; Rodis E; Buchanan A; Swartz MS
    Psychiatr Serv; 2013 Jul; 64(7):630-7. PubMed ID: 23494058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The unique treatment needs of female substance abusers in correctional institutions: the obligation of the criminal justice system to provide parity of services.
    Yang SS
    Med Law; 1990; 9(4):1018-27. PubMed ID: 2125099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial/ethnic disparities in patterns and determinants of criminal justice involvement among youth in substance abuse treatment programs.
    Godette DC; Mulatu MS; Leonard KJ; Randolph S; Williams N
    J Correct Health Care; 2011 Oct; 17(4):294-308. PubMed ID: 21821605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contingency management in cocaine abusers: a dose-effect comparison of goods-based versus cash-based incentives.
    Vandrey R; Bigelow GE; Stitzer ML
    Exp Clin Psychopharmacol; 2007 Aug; 15(4):338-43. PubMed ID: 17696680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.